BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15588815)

  • 1. Mapping the binding of the N-terminal extracellular tail of the CXCR4 receptor to stromal cell-derived factor-1alpha.
    Gozansky EK; Louis JM; Caffrey M; Clore GM
    J Mol Biol; 2005 Jan; 345(4):651-8. PubMed ID: 15588815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of positively charged residues in CXCR4 recognition probed with synthetic peptides.
    Luo Z; Zhou N; Luo J; Hall JW; Huang Z
    Biochem Biophys Res Commun; 1999 Oct; 263(3):691-5. PubMed ID: 10512741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural determinants of unexpected agonist activity in a retro-peptide analogue of the SDF-1alpha N-terminus.
    Palladino P; Tizzano B; Pedone C; Ragone R; Rossi F; Saviano G; Tancredi T; Benedetti E
    FEBS Lett; 2005 Oct; 579(24):5293-8. PubMed ID: 16182292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and characterizing mutated human stromal cell-derived factor-1 (SDF-1): C-terminal alpha-helix of SDF-1alpha plays a critical role in CXCR4 activation and signaling, but not in CXCR4 binding affinity.
    Tan Y; Du J; Cai S; Li X; Ma W; Guo Z; Chen H; Huang Z; Xiao J; Cai L; Cai S
    Exp Hematol; 2006 Nov; 34(11):1553-62. PubMed ID: 17046575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of C-terminal alpha-helix decreased SDF-1alpha-mediated signaling and chemotaxis without influencing CXCR4 internalization.
    Cai SH; Tan Y; Ren XD; Li XH; Cai SX; Du J
    Acta Pharmacol Sin; 2004 Feb; 25(2):152-60. PubMed ID: 14769202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear magnetic resonance solution structure of truncated human GRObeta [5-73] and its structural comparison with CXC chemokine family members GROalpha and IL-8.
    Qian YQ; Johanson KO; McDevitt P
    J Mol Biol; 1999 Dec; 294(5):1065-72. PubMed ID: 10600366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different stereochemical requirements for CXCR4 binding and signaling functions as revealed by an anti-HIV, D-amino acid-containing SMM-chemokine ligand.
    Dong CZ; Kumar S; Choi WT; Madani N; Tian S; An J; Sodroski JG; Huang Z
    J Med Chem; 2005 Dec; 48(25):7923-4. PubMed ID: 16335916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics simulations on SDF-1alpha: binding with CXCR4 receptor.
    Huang X; Shen J; Cui M; Shen L; Luo X; Ling K; Pei G; Jiang H; Chen K
    Biophys J; 2003 Jan; 84(1):171-84. PubMed ID: 12524273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
    Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
    Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HIV activity and conformational studies of peptides derived from the C-terminal sequence of SDF-1.
    Dettin M; Pasquato A; Scarinci C; Zanchetta M; De Rossi A; Di Bello C
    J Med Chem; 2004 Jun; 47(12):3058-64. PubMed ID: 15163187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of the alpha-chemokine SDF-1 and its receptor CXCR4 in idiopathic inflammatory myopathies.
    De Paepe B; Schröder JM; Martin JJ; Racz GZ; De Bleecker JL
    Neuromuscul Disord; 2004 Apr; 14(4):265-73. PubMed ID: 15019705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attachment of C-terminus of SDF-1 enhances the biological activity of its N-terminal peptide.
    Luo J; Luo Z; Zhou N; Hall JW; Huang Z
    Biochem Biophys Res Commun; 1999 Oct; 264(1):42-7. PubMed ID: 10527838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12).
    Veldkamp CT; Seibert C; Peterson FC; Sakmar TP; Volkman BF
    J Mol Biol; 2006 Jun; 359(5):1400-9. PubMed ID: 16725153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A syndecan-4/CXCR4 complex expressed on human primary lymphocytes and macrophages and HeLa cell line binds the CXC chemokine stromal cell-derived factor-1 (SDF-1).
    Hamon M; Mbemba E; Charnaux N; Slimani H; Brule S; Saffar L; Vassy R; Prost C; Lievre N; Starzec A; Gattegno L
    Glycobiology; 2004 Apr; 14(4):311-23. PubMed ID: 15033938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 envelope is a neutral antagonist to CXCR4 in T-cells.
    Staudinger R; Wang X; Bandrés JC
    Biochem Biophys Res Commun; 2001 Feb; 280(4):1003-7. PubMed ID: 11162626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors.
    Choi WT; Tian S; Dong CZ; Kumar S; Liu D; Madani N; An J; Sodroski JG; Huang Z
    J Virol; 2005 Dec; 79(24):15398-404. PubMed ID: 16306611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts.
    Wright LM; Maloney W; Yu X; Kindle L; Collin-Osdoby P; Osdoby P
    Bone; 2005 May; 36(5):840-53. PubMed ID: 15794931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/ CXCL12.
    Charnaux N; Brule S; Hamon M; Chaigneau T; Saffar L; Prost C; Lievre N; Gattegno L
    FEBS J; 2005 Apr; 272(8):1937-51. PubMed ID: 15819887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution studies of recombinant human stromal-cell-derived factor-1.
    Holmes WD; Consler TG; Dallas WS; Rocque WJ; Willard DH
    Protein Expr Purif; 2001 Apr; 21(3):367-77. PubMed ID: 11281710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.
    Sutton A; Friand V; Brulé-Donneger S; Chaigneau T; Ziol M; Sainte-Catherine O; Poiré A; Saffar L; Kraemer M; Vassy J; Nahon P; Salzmann JL; Gattegno L; Charnaux N
    Mol Cancer Res; 2007 Jan; 5(1):21-33. PubMed ID: 17259344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.